Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...
JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...
Lundbeck posted quarterly revenue of 6.09 billion Danish kroner ($960 million), an increase of 10% on a year ago, and adjusted EBITDA of 1.61 billion kroner, up 40%. Adjusted earnings per share (EPS) ...
Emcure Pharma's Q3 FY26 net profit rose 48% on strong domestic and international growth, as the company eyes entry into India ...
LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates multiple neurobiomarker data streams into a single, ...
Cycle Group Holdings Limited has completed its acquisition of Applied Therapeutics Inc., a clinical-stage biopharmaceutical ...
Cognision today unveiled Cognision360(TM), a groundbreaking web-based platform that consolidates multiple neurobiomarker data streams into a single, standardized system--addressing one of the ...
Cycle Group Holdings Limited ("Cycle") is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: APLT; "Applied"), a clinical-stage ...
Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment ...
Acadia Pharmaceuticals (NasdaqGS:ACAD) received a negative trend vote from the European Medicines Agency's Committee for Medicinal Products for Human Use on its Rett syndrome treatment, trofinetide.
We came across a bullish thesis on Nurix Therapeutics, Inc. on Clinical Catalysts’s Substack. In this article, we will ...
“This patent allowance in Japan further expands our global patent portfolio and strengthens Oryzon’s IP position for vafidemstat, protecting key therapeutic indications under clinical development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results